Changchun High-Tech Industry

Historical price data

Changchun High-Tech Industry's mission is to be a leading innovator in China's biopharmaceutical sector, focusing on vaccines and recombinant protein therapeutics. The company has achieved significant commercial success with blockbuster products like its recombinant human growth hormone (rhGH) and a diversified vaccine portfolio, establishing itself as a market leader in its core therapeutic areas. Its strategy is built on deep vertical integration, continuous portfolio expansion through R&D and strategic partnerships, and capitalizing on supportive national healthcare policies to drive long-term growth.

Vertically integrated platform specializing in large-scale mammalian cell culture for recombinant protein production (e.g., growth hormone) and comprehensive viral vaccine development/manufacturing (live-attenuated, inactivated).

Dominant leader in China's recombinant human growth hormone market but faces increasing competition in vaccines from other major domestic players (Sinovac, Walvax) and global giants (GSK in shingles). Competitive advantages include vertical integration, strong branding, and a powerful sales network.